1. Home
  2. KORE vs LEXX Comparison

KORE vs LEXX Comparison

Compare KORE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • LEXX
  • Stock Information
  • Founded
  • KORE 2003
  • LEXX 2004
  • Country
  • KORE United States
  • LEXX Canada
  • Employees
  • KORE N/A
  • LEXX N/A
  • Industry
  • KORE Telecommunications Equipment
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • KORE Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • KORE 50.8M
  • LEXX 49.3M
  • IPO Year
  • KORE N/A
  • LEXX N/A
  • Fundamental
  • Price
  • KORE $2.10
  • LEXX $3.01
  • Analyst Decision
  • KORE Buy
  • LEXX Strong Buy
  • Analyst Count
  • KORE 3
  • LEXX 2
  • Target Price
  • KORE $7.67
  • LEXX $11.00
  • AVG Volume (30 Days)
  • KORE 6.3K
  • LEXX 94.0K
  • Earning Date
  • KORE 11-07-2024
  • LEXX 11-18-2024
  • Dividend Yield
  • KORE N/A
  • LEXX N/A
  • EPS Growth
  • KORE N/A
  • LEXX N/A
  • EPS
  • KORE N/A
  • LEXX N/A
  • Revenue
  • KORE $284,942,000.00
  • LEXX $411,019.00
  • Revenue This Year
  • KORE $3.55
  • LEXX $82.02
  • Revenue Next Year
  • KORE $5.72
  • LEXX $95.09
  • P/E Ratio
  • KORE N/A
  • LEXX N/A
  • Revenue Growth
  • KORE 7.91
  • LEXX 34.05
  • 52 Week Low
  • KORE $1.30
  • LEXX $0.90
  • 52 Week High
  • KORE $6.45
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • KORE 45.43
  • LEXX 41.43
  • Support Level
  • KORE $2.03
  • LEXX $2.91
  • Resistance Level
  • KORE $2.25
  • LEXX $3.39
  • Average True Range (ATR)
  • KORE 0.16
  • LEXX 0.20
  • MACD
  • KORE 0.00
  • LEXX -0.02
  • Stochastic Oscillator
  • KORE 19.57
  • LEXX 13.49

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Share on Social Networks: